Remove Biotechnology Remove Development Remove Recruiting
article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Data 28
article thumbnail

The Brattle Group Interviews and Culture

Management Consulted

The most recent development was opening an office in Toronto to effectively and quickly service The Brattle Group’s cold but lovely Canadian clients. In healthcare, the firm focuses on the enormous and fast-growing sectors of pharmaceuticals, medical devices, and biotechnology. THE BRATTLE GROUP INTERVIEWS AND RECRUITING.

Groups 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business

Only 13% of directors in the energy and utilities industry consider innovation to be a major strategic challenge, but the swift growth of renewable energy companies and such developments as the use of drones for monitoring oil and gas production suggest that no industry is impervious to the forces of innovation.

article thumbnail

Teams Solve Problems Faster When They’re More Cognitively Diverse

Harvard Business

The AEM cube, a tool developed by Peter Robertson, a psychiatrist and business consultant, assesses differences in the way people approach change. We worked with a startup biotechnology company. There is a familiar saying: “We recruit in our own image.” It cannot be predicted or easily orchestrated.